Home / Inspections / 1289802

FDA Inspection 1289802 — Changzhou Qianhong Biopharma Co., Ltd.

Changzhou Qianhong Biopharma Co., Ltd. — FEI 3005275502

The FDA completed an inspection of Changzhou Qianhong Biopharma Co., Ltd. on May 10, 2023 in Changzhou. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
May 10, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Changzhou (China)

Additional Details

Mutual Recognition Agreement (MRA)

Facility

Other inspections at this facility

  • 1295032 (VAI Fri Oct 31 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1112213 (NAI Wed Oct 23 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1037659 (VAI Fri Dec 15 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 892301 (VAI Fri Aug 01 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 661070 (NAI Fri Apr 30 2010 00:00:00 GMT+0000 (Coordinated Universal Time))

Recent compliance actions

FDA data resources